Medical statistics

Stem Cell Therapy For Long Haul Covid In LA Announced By Springs Rejuvenation

Retrieved on: 
Tuesday, January 24, 2023
COVID-19, Ageing, Cardiovascular disease, Infection, National Center for Health Statistics, Government budget balance, Brain, Timeline of the COVID-19 pandemic, Rejuvenation, Needle, B cell, Pulmonary fibrosis, Respiratory system, Laboratory, Fatigue, Sleep, FDA, Myalgia, Headache, National Center for Regenerative Medicine, Immune system, Patient, Medical statistics, Severe acute respiratory syndrome coronavirus 2, Inflammation, Stem cell, Vaccine, Pharmaceutical industry

The renowned Los Angeles-based stem cell therapy clinic Springs Rejuvenation announces a new therapy for patients suffering from long Covid.

Key Points: 
  • The announcement outlines the clinic's innovative approach to tackling the causes and symptoms of what is known as 'Long Haul Covid'.
  • Stem cell therapy also bolsters the immune system to prevent reinfection and reduce the intensity of symptoms.
  • Covid patients suffering from lung damage can also find relief through the clinic's stem cell solutions.
  • Springs Rejuvenation's stem cell treatments are non-invasive and offer an effective alternative to prescription medication for the relief of chronic disorders.

Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL® (bempedoic acid) Meets Primary Endpoint

Retrieved on: 
Wednesday, December 7, 2022
Online, Bronchitis, Moyamoya disease, Atrial fibrillation, Simvastatin, Kidney, Cardiovascular disease, National Center for Health Research, Shoulder, Abdominal pain, Mortality, ANN, Pregnancy, Health, ATP, Security (finance), ESPR, Uric acid, Rotator cuff, Drug, Diet, National Center for Health Statistics, Back pain, Pravastatin, Centers for Disease Control and Prevention, Pain, CDC, World Heart Federation, Spasm, Gout, Cholesterol, Lactation, Fetus, Disease, Upper respiratory tract infection, Achilles tendon, Concentration ratio, GA, Growth, CLEAR, Risk, Medical statistics, COVID-19, Patient, Anemia, Tendon rupture, Pharmaceutical industry, Dietary supplement, Hyperuricemia, Bempedoic acid, Death, Esperies

ANN ARBOR, Mich., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting Regimen (CLEAR) Outcomes trial met its primary endpoint, demonstrating statistically significant risk reduction in MACE-4 in patients treated with 180 mg/day NEXLETOL compared to placebo.

Key Points: 
  • CLEAR Outcomes further strengthens the clinical evidence supporting the role of bempedoic acid for patients.”
    Cardiovascular disease remains the number one killer globallyi.
  • A large proportion of patients at risk for cardiovascular events based on elevated LDL-cholesterol and apolipoprotein b are not adequately treated with existing therapies.
  • Despite recent therapeutic advances, there remains a significant need for new treatment options to help improve long-term cardiovascular outcomesii.
  • Limitations of Use: The effect of NEXLETOL on cardiovascular morbidity and mortality has not been determined.

Arizona Experiencing Increase in Illicit Fentanyl Exposure

Retrieved on: 
Thursday, December 8, 2022
Mental Health, Public Policy, Government, Health, State, Local, Other Health, Pharmaceutical, Doctor of Pharmacy, JAMA Network Open, Speech disorder, Medical statistics, National Center for Health Research, Drug overdose, Fentanyl, Public health, Chronic pain, UDT, Illegal drug trade, Veni, vidi, vici, DEA, Death, Multimedia, Education, CPE, Drug Enforcement Administration, Urine, CDC, National Center for Health Statistics, Pharmaceutical industry, Medical device, Drug

Millennium Health announced today that illicit fentanyl positivity in Arizona increased by 261% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019.

Key Points: 
  • Millennium Health announced today that illicit fentanyl positivity in Arizona increased by 261% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019.
  • View the full release here: https://www.businesswire.com/news/home/20221208005157/en/
    Arizona saw a 260% increase in fentanyl positivity in the first half of 2022 compared to all of 2019 based on real-time analysis of urine drug test results by Millennium Health.
  • (Graphic: Business Wire)
    A dramatic increase in drug overdose deaths is being reported across the U.S.
  • We also conduct real-time tracking of emerging drug use trends to help researchers, public health officials, and policymakers address the significant increase in drug overdose deaths.

In a State Ravaged by Drug Overdoses, Spero Health Brings Lifesaving Addiction Treatment to Beckley, West Virginia

Retrieved on: 
Tuesday, December 6, 2022
General Health, Mental Health, Hospitals, Health, Pharmaceutical, Synthetic, Housing, United States drug overdose death rates and totals over time, National Center for Health Statistics, Medical statistics, Drug overdose, Fentanyl, Patient, Employment, Health, Methamphetamine, Medicaid, Insurance, Death, Heritage, Senior, Food, Hope, Topical steroid withdrawal, CDC, Pharmaceutical industry, Hospital

Located at 122 Professional Park, this new clinic marks the 3rd location Spero Health has opened in the state that joins a network of more than 95 Spero Health locations throughout Kentucky, Ohio, Tennessee, Indiana, Virginia.

Key Points: 
  • Located at 122 Professional Park, this new clinic marks the 3rd location Spero Health has opened in the state that joins a network of more than 95 Spero Health locations throughout Kentucky, Ohio, Tennessee, Indiana, Virginia.
  • Spero Health is in network with West Virginia Medicaid and most commercial insurance plans to ensure cost is not a barrier to treatment.
  • Spero Health is responding to these staggering statistics by expanding addiction treatment services across states most impacted by the drug epidemic, so communities have access to lifesaving care close to home.
  • This is our third clinic in West Virginia, and it is just the beginning of our work in the state.

Pinnacle Treatment Centers Acquires MBA Wellness Center in Georgia

Retrieved on: 
Thursday, December 8, 2022
General Health, Mental Health, Alternative Medicine, Other Health, Health, Desert Hope Addiction Treatment Center, United States drug overdose death rates and totals over time, US Market Access Center, Georgia Department of Labor, Opioid use disorder, Medical statistics, Drug overdose, Fentanyl, Hospital, Wellness, Opioid, Patient, Stepping Stones Museum for Children, Peach, Disease, Medicaid, Methadone, Death, News, Public health, Passages Malibu, MAT, Gold, Health, Heroin, Corporate development, Georgia Department of Public Health, Medicare, Acquisition, Cereal, Pharmaceutical industry, Pinnacle, Atlanta

Pinnacle Treatment Centers , a leading provider of community-based drug and alcohol addiction treatment services, announced today it has acquired MBA Wellness Center in Stockbridge, Georgia.

Key Points: 
  • Pinnacle Treatment Centers , a leading provider of community-based drug and alcohol addiction treatment services, announced today it has acquired MBA Wellness Center in Stockbridge, Georgia.
  • Founded in 2010, MBA Wellness Center is a privately-owned, outpatient opioid addiction treatment program located approximately 20 miles south of Atlanta in Eagles Point Professional Building at 1233 Eagles Landing Parkway.
  • Pinnacle entered the Peach State in August 2020 when it purchased HealthQwest , an opioid addiction treatment provider with five locations.
  • MBA Wellness Center will take the HealthQwest name, and together, the six centers will help more than 1,300 patients every day overcome opioid use disorder.

New Research Shows Two Cups of Tea a Day May Keep the Doctor Away

Retrieved on: 
Wednesday, December 7, 2022
Online, Drinking, Agency for Healthcare Research and Quality, Dietitian, GA, Medical statistics, National Center for Healthy Housing, MEPS, Centers for Disease Control and Prevention, Doctor of Philosophy, Science, Quality, Academy of Nutrition and Dietetics, Partnership, Research, Advances in Nutrition, 2009 Davis Cup, Meta-analysis, Medical Expenditure Panel Survey, Tea, Area studies, Drink, Nutrient, Disease, U.S.A, Diabetes, Cardiovascular disease, Woman, Multimedia, Diet, Council, Degenerative disease, Cholesterol, Health, Systematic review, North Eastern Tea Association, Blood pressure, Stroke, CDC, National Center for Health Statistics, Risk, Dietary supplement, Coffee, Pharmaceutical industry, Nutrition, Food, Death, RD

NEW YORK, Dec. 7, 2022 /PRNewswire/ -- While scientific evidence has supported the health properties of tea's bioactive compounds, there is now guidance on how much of these nutrients we need to consume for health benefits. New guidelines published in Advances in Nutrition have extrapolated data from published research to form dietary recommendations for flavan-3-ol intake. This research and guidance is the culmination of a collaboration between the Institute for the Advancement of Food and Nutrition Science, an international expert panel and The Academy of Nutrition and Dietetics to release recommendations for specific quantities of flavan-3-ols to consume daily to reap health benefits.

Key Points: 
  • New guidelines published in Advances in Nutrition have extrapolated data from published research to form dietary recommendations for flavan-3-ol intake.
  • Data shows that consumption of 400-600mg of flavan-3-ols daily (about 2 cups of brewed green or black tea) can help improve blood pressure, cholesterol, and blood sugar.
  • Flavan-3-ols are plant compounds found in many foods and drinks, such as tea, berries, craisins, apples, and dark chocolate.
  • Following these guidelines, research suggests health benefits can be seen from consuming about two, eight-ounce cups of green or black tea each day.

Fingerpaint Group Launches Edgy Campaign to Help Men See Therapy as a Strength, Not a Weakness

Retrieved on: 
Wednesday, November 30, 2022
Aiden, Mental health, Marketing, D, DE, Suicide, National Alliance, Social media, Depression, National Center for Health Statistics, Creativity, Friends, National Center for Trauma-Informed Care, National Health, Anxiety, Clio Awards, NCHS, National Alliance on Mental Illness, Medical statistics, Global Awards, Collection, The Best Place to Be, Woman, Mental disorder, Centers for Disease Control and Prevention, Toy, Pharmaceutical industry, Tourism, Fingerpaint, Telly

SARATOGA SPRINGS, N.Y., Nov. 30, 2022 /PRNewswire/ -- Fingerpaint Group has launched Unf*ck Your Feelings, a social campaign focused on encouraging men, specifically between the ages of 18 and 30, to seek mental health resources when they need it. Timed to coincide with Men's Health Awareness Month, the campaign uses social media influencers to demonstrate the benefits of seeking help and provides a comprehensive list of mental health resources, such as the National Alliance on Mental Illness, Insight Timer, mental health providers, crisis hotlines, online support groups, and more at www.unfckyourfeelings.com.

Key Points: 
  • National Center for Health Statistics (NCHS) Data Brief suggests that men's resistance to therapy is literally killing them.
  • Men have 4 times the rate of suicide as women according to the NCHS data.
  • Men especially need help to start the conversation, and this platform can act as the catalyst for that change."
  • Fingerpaint Group is composed of marketing services including Fingerpaint, Fingerpaint Multicultural, and Engage; and specialty services including Fingerpaint Market Access, Leaderboard Branding, MedThink Communications, MedThink SciCom, and Parsons Medical Communications.

Qualis Innovations Inc. recently announces its financial results along with updated form Company’s Chief Executive

Retrieved on: 
Thursday, November 17, 2022
Marketing, Skin, Radio, Biomedical Advanced Research and Development Authority, Risk, Therapy, Gallup (company), Internal medicine, Research, Drug development, Medical statistics, SGE, Anesthesiology, Patient, Television, Qualis (CAPES), Gallup, Ford Motor Company, FDA, Growth, Drug overdose, Hospital, Death, Consolation, Food and Drug Administration, Pain management, Consultant, Department of Medicine – University of Pamplona, Acquisition, 2021 Essex County Council election, Palliative care, Pharmacology, Opioid, Central nervous system, CNS, Nova, Johns Hopkins School of Medicine, General partnership, Pharmaceutical industry, Risk management, Medicine

Chadds Ford, Pennsylvania, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Qualis Innovations Inc. currently trades under symbol QLIS, recently announced its financial 10-Q report on November 14, 2022.

Key Points: 
  • Chadds Ford, Pennsylvania, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Qualis Innovations Inc. currently trades under symbol QLIS, recently announced its financial 10-Q report on November 14, 2022.
  • Dr. Joseph Pergolizzi provided the following update to the Companys progress and direction
    As acting Chief Executive Officer of Qualis Innovations, I want to thank you for your support for Qualis Innovations and for your loyalty and patience while we work to build value in your company.
  • I am an experienced C-suite executive who brings an extensive professional network and background in global healthcare to Qualis.
  • Please visit our SEC filings or Company's website for more information on the full results and management's plan.

MiCare Path Joins the Innovators' Network at American Heart Association (AHA) Center for Health Technology & Innovation and Will Integrate AHA Digital Science-Based CarePlans into Its Platform

Retrieved on: 
Wednesday, November 2, 2022
Online, American Heart Association, MPH, 2009 Davis Cup, FRCPE, Organization, NIH, MHealth, Department, FESC, Hospital, Man, FAHA, American College of Cardiology, Center, Solution, Science, Risk, Korea Disease Control and Prevention Agency, CEO, Stanford University, Health, Partnership, Collaborative innovation network, Division, Blood pressure, National Center for Health Statistics, Technology, Degenerative disease, AHA, Health education, Innovation, Patient, Multimedia, CDC, Le Bonheur Children's Hospital, Sleep, Diet, Physician, Centers for Disease Control and Prevention, St. Jude Children's Research Hospital, Volunteering, Woman, FAAP, Annals of Pediatric Cardiology, National, Tablet, Death, Cholesterol, Adult, FACC, GA, Medicine, Blood, Association, Medical statistics, Medical device, Pharmaceutical industry, MD, Cardiology, Network, Facebook

MEMPHIS, Tenn., Nov. 2, 2022 /PRNewswire/ -- MiCare Path, a platform that optimizes patient care through remote patient monitoring, has joined the AHA for Health Technology & Innovation's Innovators' Network (the Center). The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions. MiCare Path will utilize CarePlans and digital science to deliver the future of healthcare, today.

Key Points: 
  • The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.
  • MiCare Path will utilize CarePlans and digital science to deliver the future of healthcare, today.
  • Innovators' Network members also have access to the Association's digital guidelines, recommendations and premier science as they develop digital healthcare technologies.
  • The National Institutes of Health (NIH) defines mHealth as: the use of mobile and wireless devices (cell phones, tablets, etc.)

The Worldwide Textured Vegetable Protein Industry is Expected to Reach $1.9 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 31, 2022
Food, Beverage, Retail, Carbohydrate, American Journal, NCHS, Water, World, Obesity, Protein, Environmental impact of meat production, Soybean, Region, Ultrafiltration, Dry, Meat, Slices, USD, CHD, Moyamoya disease, Risk, TVP, Food, Growth, Centrifugation, Nature, Filtration, National Centre for Cold-chain Development, Medical statistics, CAGR, American Journal of Epidemiology, Ageing, Food preservation, Form

The global textured vegetable protein market is estimated to be valued at USD 1.4 billion in 2022.

Key Points: 
  • The global textured vegetable protein market is estimated to be valued at USD 1.4 billion in 2022.
  • It is projected to reach USD 1.9 billion by 2027, recording a CAGR of 6.9% during the forecast period.
  • It has been the dominant country regarding textured vegetable protein demand and supply.
  • The increase in the use of alternative meat in various food applications has driven the demand for textured vegetable protein.